CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Vivione Biosciences Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Vivione Biosciences Inc
Eight Greenway Plaza, Suite 1320
Phone: (713) 475-0321p:713 475-0321 HOUSTON, TX  77046  United States Ticker: PIA.PPIA.P

Business Summary
Vivione Biosciences Inc. is a holding company which is currently reviewing potential acquisitions. The Company’s subsidiary is Vivione Biosciences, LLC.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/201812/31/2017Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chief Financial Officer Chester J.Jachimiec 12/31/2013 6/21/2011
Independent Director James K.Hendren 7/18/2013 7/18/2013
Independent Director Glenn W.Smith 7/18/2013 7/18/2013
Independent Director Philip A.Tuttle 77 1/1/2015 6/21/2011

Business Names
Business Name
PIA
PIA.P
VBI.H

General Information
Outstanding Shares: 68,989,848 (As of 9/30/2018)
Stock Exchange: NEX
Fax Number: (509) 561-7287


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, December 31, 2023